A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder is a research paper published in The International Journal of Neuropsychopharmacology (2020). On theSindex it has a DataRank of 0.554. It has been cited 14 times, with 10 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0.148
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
U.S. National Institutes of Health
Grant: P30 DA046345
ClinicalTrials.gov
Grant: NCT02357901
National Institutes of Health
Grant: 5P30DA046345-04
Penn PET Addiction Center of Excellence (Penn PACE)
National Institute on Drug Abuse
FWCI
2.05
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals